CY1108255T1 - Μεθοδος για τη συνθεση μιας ενωσης βενζιμιδαζολης - Google Patents
Μεθοδος για τη συνθεση μιας ενωσης βενζιμιδαζοληςInfo
- Publication number
- CY1108255T1 CY1108255T1 CY20081100852T CY081100852T CY1108255T1 CY 1108255 T1 CY1108255 T1 CY 1108255T1 CY 20081100852 T CY20081100852 T CY 20081100852T CY 081100852 T CY081100852 T CY 081100852T CY 1108255 T1 CY1108255 T1 CY 1108255T1
- Authority
- CY
- Cyprus
- Prior art keywords
- benzimidazolis
- union
- composition
- water
- reaction sequence
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- PSEPRWKZZJWRCB-UHFFFAOYSA-N (4-methoxy-3,5-dimethylpyridin-2-yl)methanol Chemical compound COC1=C(C)C=NC(CO)=C1C PSEPRWKZZJWRCB-UHFFFAOYSA-N 0.000 abstract 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical compound C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 abstract 1
- 229960004770 esomeprazole Drugs 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 229960000381 omeprazole Drugs 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0203092A SE0203092D0 (en) | 2002-10-18 | 2002-10-18 | Method for the synthesis of a benzimidazole compound |
| EP03751703A EP1556370B1 (en) | 2002-10-18 | 2003-10-15 | Method for the synthesis of a benzimidazole compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108255T1 true CY1108255T1 (el) | 2014-02-12 |
Family
ID=20289310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100852T CY1108255T1 (el) | 2002-10-18 | 2008-08-12 | Μεθοδος για τη συνθεση μιας ενωσης βενζιμιδαζολης |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US7227024B2 (enExample) |
| EP (1) | EP1556370B1 (enExample) |
| JP (1) | JP4551221B2 (enExample) |
| KR (1) | KR101065885B1 (enExample) |
| CN (2) | CN101230057B (enExample) |
| AR (1) | AR041639A1 (enExample) |
| AT (1) | ATE398118T1 (enExample) |
| AU (1) | AU2003269773B2 (enExample) |
| BR (1) | BR0315254A (enExample) |
| CA (1) | CA2501542C (enExample) |
| CY (1) | CY1108255T1 (enExample) |
| DE (1) | DE60321588D1 (enExample) |
| DK (1) | DK1556370T3 (enExample) |
| ES (1) | ES2306883T3 (enExample) |
| IL (1) | IL167795A (enExample) |
| IS (1) | IS2590B (enExample) |
| MX (1) | MXPA05003994A (enExample) |
| MY (1) | MY133573A (enExample) |
| NO (1) | NO330785B1 (enExample) |
| NZ (1) | NZ539370A (enExample) |
| PL (1) | PL376819A1 (enExample) |
| PT (1) | PT1556370E (enExample) |
| RU (1) | RU2324691C2 (enExample) |
| SA (1) | SA03240344B1 (enExample) |
| SE (1) | SE0203092D0 (enExample) |
| SI (1) | SI1556370T1 (enExample) |
| TW (1) | TWI310382B (enExample) |
| UA (1) | UA79147C2 (enExample) |
| UY (1) | UY28025A1 (enExample) |
| WO (1) | WO2004035565A1 (enExample) |
| ZA (1) | ZA200502577B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0203092D0 (en) * | 2002-10-18 | 2002-10-18 | Astrazeneca Ab | Method for the synthesis of a benzimidazole compound |
| WO2006064249A2 (en) * | 2004-12-16 | 2006-06-22 | Cipla Limited | Process for the preparation of pantoprazole sodium |
| WO2010134099A1 (en) | 2009-05-21 | 2010-11-25 | Cadila Healthcare Limited | One pot process for preparing omeprazole and related compounds |
| EP2510089B1 (en) | 2009-12-08 | 2015-10-21 | Codexis, Inc. | Synthesis of prazole compounds |
| DK2649187T3 (da) | 2010-12-08 | 2018-01-29 | Codexis Inc | Biokatalysatorer og fremgangsmåder til syntesen af armodafinil |
| CN103570681A (zh) * | 2012-07-24 | 2014-02-12 | 江苏柯菲平医药有限公司 | 一种埃索美拉唑关键中间体的制备方法 |
| CN103232389A (zh) * | 2013-05-08 | 2013-08-07 | 浙江新三和医药化工股份有限公司 | 2-氯甲基-4-甲氧基-3,5-二甲基吡啶盐酸盐的制备方法 |
| CN103524494A (zh) * | 2013-11-07 | 2014-01-22 | 安徽国星生物化学有限公司 | 含甲基吡啶基团的巯基咪唑类衍生物及合成方法 |
| CN108251466B (zh) * | 2016-12-28 | 2021-07-02 | 浙江京新药业股份有限公司 | 一种酶法合成埃索美拉唑的方法 |
| CN107400118B (zh) * | 2017-08-29 | 2020-07-28 | 信泰制药（苏州）有限公司 | 埃索美拉唑中间体的制备方法 |
| CN111943883A (zh) * | 2020-08-21 | 2020-11-17 | 抚州三和医药化工有限公司 | 一种奥美氯化物的生产工艺 |
| KR20220084718A (ko) | 2020-12-14 | 2022-06-21 | 메디케어제약 주식회사 | 기능성 소화 불량을 동반한 위식도 역류 질환을 치료하는 약제학적 복합제제 |
| KR20230090184A (ko) | 2021-12-14 | 2023-06-21 | 메디케어제약 주식회사 | 에스오메프라졸 및 레바미피드를 포함하는 약제학적 복합제제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4619997A (en) | 1984-09-06 | 1986-10-28 | The Upjohn Company | Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents |
| SE9002043D0 (sv) | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
| WO1993006097A1 (en) | 1991-09-20 | 1993-04-01 | Merck & Co., Inc. | Novel process for the preparation of anti-ulcer agents |
| KR100236853B1 (ko) * | 1995-07-03 | 2000-02-01 | 야마모토 카즈모토 | 1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물 |
| SE521100C2 (sv) * | 1995-12-15 | 2003-09-30 | Astra Ab | Förfarande för framställning av en bensimidazolförening |
| SE9704183D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New process |
| SI20019A (sl) * | 1998-07-13 | 2000-02-29 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola |
| SE0203092D0 (en) * | 2002-10-18 | 2002-10-18 | Astrazeneca Ab | Method for the synthesis of a benzimidazole compound |
-
2002
- 2002-10-18 SE SE0203092A patent/SE0203092D0/xx unknown
-
2003
- 2003-10-09 TW TW092128112A patent/TWI310382B/zh not_active IP Right Cessation
- 2003-10-14 SA SA03240344A patent/SA03240344B1/ar unknown
- 2003-10-15 RU RU2005109270/04A patent/RU2324691C2/ru active
- 2003-10-15 WO PCT/SE2003/001602 patent/WO2004035565A1/en not_active Ceased
- 2003-10-15 NZ NZ539370A patent/NZ539370A/en not_active IP Right Cessation
- 2003-10-15 CN CN2008100040145A patent/CN101230057B/zh not_active Expired - Lifetime
- 2003-10-15 DK DK03751703T patent/DK1556370T3/da active
- 2003-10-15 AU AU2003269773A patent/AU2003269773B2/en not_active Expired
- 2003-10-15 EP EP03751703A patent/EP1556370B1/en not_active Expired - Lifetime
- 2003-10-15 DE DE60321588T patent/DE60321588D1/de not_active Expired - Lifetime
- 2003-10-15 PL PL376819A patent/PL376819A1/pl unknown
- 2003-10-15 MX MXPA05003994A patent/MXPA05003994A/es active IP Right Grant
- 2003-10-15 UA UAA200502927A patent/UA79147C2/uk unknown
- 2003-10-15 SI SI200331301T patent/SI1556370T1/sl unknown
- 2003-10-15 AT AT03751703T patent/ATE398118T1/de active
- 2003-10-15 ES ES03751703T patent/ES2306883T3/es not_active Expired - Lifetime
- 2003-10-15 JP JP2004545137A patent/JP4551221B2/ja not_active Expired - Fee Related
- 2003-10-15 CN CNB2003801014302A patent/CN100374436C/zh not_active Expired - Lifetime
- 2003-10-15 KR KR1020057006554A patent/KR101065885B1/ko not_active Expired - Fee Related
- 2003-10-15 CA CA2501542A patent/CA2501542C/en not_active Expired - Fee Related
- 2003-10-15 BR BR0315254-5A patent/BR0315254A/pt not_active IP Right Cessation
- 2003-10-15 US US10/531,412 patent/US7227024B2/en not_active Expired - Lifetime
- 2003-10-15 PT PT03751703T patent/PT1556370E/pt unknown
- 2003-10-16 AR ARP030103769A patent/AR041639A1/es not_active Application Discontinuation
- 2003-10-16 MY MYPI20033949A patent/MY133573A/en unknown
- 2003-10-16 UY UY28025A patent/UY28025A1/es not_active Application Discontinuation
-
2005
- 2005-03-30 ZA ZA200502577A patent/ZA200502577B/en unknown
- 2005-03-31 IL IL167795A patent/IL167795A/en not_active IP Right Cessation
- 2005-05-02 NO NO20052158A patent/NO330785B1/no not_active IP Right Cessation
- 2005-05-03 IS IS7834A patent/IS2590B/is unknown
-
2007
- 2007-05-16 US US11/749,282 patent/US7683178B2/en not_active Expired - Lifetime
-
2008
- 2008-08-12 CY CY20081100852T patent/CY1108255T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108255T1 (el) | Μεθοδος για τη συνθεση μιας ενωσης βενζιμιδαζολης | |
| DE60028732D1 (de) | Verfahren zur erhaltung der dns-integrität | |
| BR0210839A (pt) | Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico | |
| ATE191513T1 (de) | Verfahren zur amplifikation von nukleinsäuren | |
| DK1676117T3 (da) | Simplificeret forarbejdning af væv | |
| ATE255168T1 (de) | Massenspektroskopische verfahren zur sequenzierung von nukleinsäuren | |
| CY1111278T1 (el) | Συστημα ασφαλειας | |
| DE602006016326D1 (de) | Kompakte vorrichtung, zusammensetzungen und verfahren zur reinigung von nukleinsäuren | |
| CY1107564T1 (el) | Πολυμορφο του 4-[2-[4-[1-(2-αιθοξυαιθυλ)-1η-βενζιμιδαζολ-2-υλ]-1-πιπepιδινυλ]αιθυλ]αιθυλ-αλφα, αλφα-διμεθυλ-βενζενοξικου οξεος | |
| ATE463294T1 (de) | Verfahren zur konzentration und reinigung von biologischen verbindungen | |
| ATE515498T1 (de) | Verfahren zur aufreinigung von montelukast und dessen aminsalzen | |
| ATE517094T1 (de) | Verfahren zur herstellung von medetomidin und seinen salzen | |
| ATE407703T1 (de) | Verbindungen und kits zur herstellung von bildgebenden mitteln und bildgebungsverfahren | |
| FI20011664A7 (fi) | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö | |
| ATE397098T1 (de) | Verfahren zur diagnostik von eierstock endometriose | |
| DE69824839D1 (de) | Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren | |
| ATE212382T1 (de) | Verfahren zur sequenzierung durch oligomerhybridisierung | |
| ATE253037T1 (de) | Verfahren zur racematspaltung von tramadol | |
| ATE344273T1 (de) | Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op) | |
| ATE391115T1 (de) | Verfahren zur herstellung von diketenacetalen | |
| DE50210818D1 (de) | Verfahren zur genexpression | |
| DK1161562T3 (da) | Deleterede sekvenser i M. bovis BCG/M. bovis eller M. tuberculosis, fremgangsmåde til påvisning af mykobakterier ved anvendelse af sekvenserne og vacciner | |
| DE50206574D1 (de) | Verfahren zur herstellung eines arrays zur detektion von komponenten aus einer biologischen probe | |
| ATE391113T1 (de) | Verfahren zur herstellung von pentafluorethan | |
| ATE453859T1 (de) | Verfahren zum nachweis einer reaktion zur molekularen erkennung |